Compounds > 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol
Page last updated: 2024-09-03

1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and rsu 1172

1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol has been researched along with rsu 1172 in 1 studies

Compound Research Comparison

Studies
(1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol)		Trials
(1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol)		Recent Studies (post-2010)
(1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol)		Studies
(rsu 1172)		Trials
(rsu 1172)		Recent Studies (post-2010) (rsu 1172)
1900500

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, I; Deacon, JM; Holliday, SB; Jenkins, TC1

Other Studies

1 other study(ies) available for 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and rsu 1172

ArticleYear
Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios.
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:7

    Topics: Animals; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Radiation-Sensitizing Agents

1986